Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest chronic bronchitis Stories

2014-01-14 12:26:46

BETHESDA, Md., Jan. 14, 2014 /PRNewswire/ -- Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced that the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, has released its first draft qualification guidance document for a patient-reported outcome (PRO) measure in drug development: Qualification of Exacerbations of Chronic Pulmonary Disease Tool [EXACT] for Measurement of Symptoms of Acute Bacterial...

Yoga Can Help Patients With COPD Improve Lung Function
2013-10-29 06:18:51

April Flowers for redOrbit.com - Your Universe Online A new study from researchers at the All India Institute of Medical Sciences, Department of Pulmonary Medicine and Sleep Disorders reveals that patients with COPD can improve their lung function by practicing yoga. The study found that lung function, shortness of breath and inflammation all demonstrated significant improvement after patients completed 12 weeks of yoga training. The study results were presented at CHEST 2013, the...

2013-09-08 20:20:26

Phase 3 results presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 RIDGEFIELD, Conn., Sept. 8, 2013 /PRNewswire/ -- Data from the olodaterol Phase 3 clinical program, presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, showed the addition of olodaterol 5 and 10 mcg delivered once daily via the Respimat(®) inhaler provided improvements in lung function in patients with moderate to very severe...

2013-04-17 16:26:46

LONDON and SOUTH SAN FRANCISCO, Calif., April 17, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC) to the US Food and Drug Administration (FDA) voted that the efficacy and safety data provide substantial evidence to support approval of BREO(TM) ELLIPTA(TM) as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic...

2012-09-02 02:20:38

VIENNA, September 2, 2012 /PRNewswire/ -- - New Expert Report on COPD Launched at a Press Conference at ERS 2012 - Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria. To view the Multimedia News Release, please click:...

2012-06-06 10:25:35

MISSION VIEJO, Calif., June 6, 2012 /PRNewswire/ -- Lifescript.com, a women's health and wellness website headquartered in Mission Viejo, Calif., has launched a new online COPD Health Center to help women detect, treat and reduce risk factors for Chronic Obstructive Pulmonary Disease. COPD, the third leading cause of death in the United States, is a progressive illness that affects airflow out of the lungs, causing difficulty breathing. COPD is a group of interrelated diseases, the two most...

2012-05-21 11:47:22

For more than three decades, researchers have warned of the potential health risks associated with exposure to environmental tobacco smoke (ETS), especially among children whose parents smoke. Now a new study conducted by researchers from the University of Arizona reports that those health risks persist well beyond childhood, independent of whether or not those individuals end up becoming smokers later in life. The study will be presented at the ATS 2012 International Conference in San...

2012-01-12 06:00:00

SAN FRANCISCO, Jan. 12, 2012 /PRNewswire/ -- Inverseon, Inc., a pharmaceutical company developing drug therapies for the treatment of pulmonary disorders, announced that while it anticipates that its asthma program will advance with non-dilutive grants, it is focused on smoking cessation as the initial indication for INV102. William J. Garner, MD, Chairman, said, "The prioritization of smoking cessation, and also an inhaled COPD program, makes sense for Inverseon given the regulatory hurdles...

2011-10-18 20:39:17

Findings Offer Potential New Drug Target for COPD Therapy Chronic obstructive pulmonary disease (COPD) leads to persistent inflammation of the airways and is typically managed with corticosteroids, a class of anti-inflammatory medication. However, corticosteroids do not improve survival nor alter the progression of COPD and may reduce lung symptoms as little as 20 percent. A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, found why corticosteroids do...

2011-10-06 10:23:00

CHICAGO, Oct. 6, 2011 /PRNewswire-USNewswire/ -- Data released with the 2010 Illinois Behavioral Risk Factor Surveillance Survey (BRFSS) shows that more than 60% of the people living with chronic obstructive pulmonary disease (COPD) experience shortness of breath so severe that it affects their quality of life. COPD is caused by airflow blockage and damaged lung tissue, and it includes chronic bronchitis and emphysema. It is the third leading cause of death in the U.S. People living with...